COMPUMEDICS SECURES LUCRATIVE BRAZIL DEAL

Posted on May 20, 2014

  • Compumedics’ Germany based business has secured a EUR200K agreement to supply equipment for stroke prevention and treatment in Brazil’
  • The deal which will equip 10 stroke centers across Brazil is a further entry point into the Latin American market

Compumedics Limited (ASX: CMP) is pleased to announce that the Company’s Germany-based brain blood-flow Doppler-sonography division, Compumedics Germany GmbH (“DWL”), has secured a EUR200K deal to supply its Doppler-Box X technology to 10 stroke centers across Brazil.

The agreement will enable DWL to build its reputation and footprint in Brazil and Latin America, cementing DWL’s position as one of the world’s leading suppliers of brain blood-flow technology.

In commenting on the Brazil contract win, Mr. Witte, Managing Director for DWL, said:

“This contract is an important achievement for DWL and Compumedics. It follows the EUR400K agreement that we secured in Brazil in 2012 and confirms our strong position in the country as well as our winning strategy for the Latin American market.”

In commenting on the boost to Compumedics’ business across Latin America, Dr. David Burton, Chairman and CEO, said:

“The DWL business continues to expand its presence in global markets and winning this deal provides an excellent opportunity for Compumedics to build our presence in Brazil and Latin America. More importantly, it shows that all parts of the Compumedics Group remain focused on renewing growth, as we continue to restore and strengthen our financial position.”

About Compumedics Limited

Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovatorby the both German and Australian Governments.